PIK3C2A and myositis disease: Although previous studies showed that both increased and decreased levels of CPK could be risk factors for malignancy in myositis20,46–49, our findings suggested that lower serum levels of CPK were associated with myositis with malignancy, and this finding might be attributed to effects on the PD-L1 pathway and T cell senescence.